• Triazole ALDH2 Activators: Breakthroughs in Myocardial Ische

  2026-07-20

  This study presents the discovery and optimization of novel triazole-based ALDH2 activators, culminating in a lead compound with unprecedented activation potency and water solubility. These advances demonstrate significant cardioprotective effects in preclinical models, offering a promising foundation for new therapeutic approaches to myocardial ischemia-reperfusion injury.

• Biotin-16-UTP: Precision RNA Labeling for Advanced Detection

  2026-07-20

  Biotin-16-UTP streamlines high-sensitivity RNA detection and purification, enabling researchers to map RNA-protein interactions with unprecedented clarity. Its versatility in in vitro transcription RNA labeling makes it indispensable for mechanistic studies in cancer biology and beyond.

• Chlorambucil: Nitrogen Mustard Alkylating Agent in Cell Assa

  2026-07-19

  Chlorambucil stands out as a rigorously validated nitrogen mustard alkylating agent for DNA crosslinking and apoptosis induction, especially in leukemia and glioma research. This guide delivers actionable protocols, troubleshooting strategies, and practical insights for maximizing reproducibility and sensitivity in cytotoxicity assays using APExBIO’s Chlorambucil.

• Brassinolide in Research: Protocols, Applications & Innovati

  2026-07-18

  Brassinolide stands apart as a dual-domain tool for both plant biology and cancer research, empowering reproducible apoptosis and growth assays. Explore setup, optimized workflows, and troubleshooting grounded in recent structure–activity insights.

• Isoproterenol Sulfate Dihydrate in Human Cardiac Assembloids

  2026-07-17

  Isoproterenol sulfate dihydrate enables precision activation of beta-adrenergic signaling in next-generation human cardiac assembloid models. This guide delivers actionable workflows, troubleshooting insights, and protocol optimization rooted in the latest neuro-cardiac research advances.

• Tamoxifen in Precision Genetics: Safety, Mechanisms, and Bes

  2026-07-17

  Explore the advanced mechanisms and safety insights of Tamoxifen as a selective estrogen receptor modulator in breast cancer research and CreER-mediated gene knockout. This article uniquely addresses dose-dependent developmental effects, bridging translational practice with rigorous assay design.

• Structure-Based Screening Reveals NSP15 Inhibitors for SARS-

  2026-07-16

  This study applies a structure-based virtual screening approach to identify natural product inhibitors targeting NSP15, a key endoribonuclease in SARS-CoV-2. The work highlights thymopentin and oleuropein as potent and stable binders, underscoring the potential for drug repurposing strategies against COVID-19.

• Bradykinin (BA5201): Technical Guidance for Vasodilator Work

  2026-07-16

  Bradykinin (BA5201) is designed for researchers modeling endothelium-dependent vasodilation, vascular permeability modulation, and related smooth muscle contraction. It enables accurate simulation of inflammatory and pain pathway mechanisms in preclinical assay systems. This product is not intended for diagnostic or medical use, and is not suitable for long-term solution storage or studies requiring stability beyond recommended handling.

• Pseudo-UTP in mRNA Synthesis: Enhancing RNA Stability & Vacc

  2026-07-15

  Pseudo-modified uridine triphosphate (Pseudo-UTP) is revolutionizing mRNA workflows, driving breakthroughs in vaccine development and gene therapy. Its integration not only boosts RNA stability and translation but also unlocks new frontiers in low-immunogenicity therapeutic design.

• Ibotenic Acid: NMDA Receptor Agonist for Disease Modeling

  2026-07-15

  Ibotenic acid stands out as a robust NMDA receptor agonist, enabling targeted neural lesioning and circuit mapping in preclinical neurodegenerative disease models. Learn how to optimize protocols and troubleshoot common challenges with APExBIO’s high-purity ibotenic acid to achieve reproducible, insightful results in neuroscience research.

• T-5224 (C-Fos/AP-1 Inhibitor): Advanced Protocols and Applic

  2026-07-14

  T-5224, a selective C-Fos/AP-1 inhibitor from APExBIO, empowers researchers to dissect inflammatory, osteoclastogenic, and oncogenic pathways with unmatched specificity. This article delivers practical protocol enhancements, troubleshooting advice, and new translational applications, including ferroptosis induction in multiple myeloma models.

• A-769662: Unraveling AMPK Activation and Autophagy Regulatio

  2026-07-14

  Explore how the AMPK activator A-769662 redefines energy metabolism and autophagy regulation. This article uniquely examines recent paradigm-shifting research, offering practical assay insights for metabolic and proteasome studies.

• ELF4 Drives Colorectal Cancer Metastasis via FGF19-FGFR4/SRC

  2026-07-13

  This study reveals that FGF19-induced overexpression of ELF4 promotes colorectal cancer metastasis by directly upregulating FGFR4 and SRC, which correlates with poor patient prognosis. Targeting this ELF4-driven axis could open novel therapeutic strategies for metastatic colorectal cancer.

• Bay 11-7821 (BAY 11-7082): Precision IKK Inhibition in Immun

  2026-07-13

  Bay 11-7821 (BAY 11-7082) stands out as a selective IKK inhibitor, empowering advanced studies in inflammatory signaling and apoptosis regulation. Its robust, dose-dependent suppression of the NF-κB pathway makes it indispensable in workflows targeting immune modulation and cancer research.

• Gut Dysbiosis Drives Prostate Cancer via NF-κB-IL6-STAT3 Axi

  2026-07-12

  Zhong et al. (2022) demonstrate that gut dysbiosis accelerates prostate cancer progression and chemoresistance through the NF-κB-IL6-STAT3 signaling pathway. Their multi-tiered study integrates mouse models, clinical samples, and mechanistic interrogation, highlighting the microbiota's indirect role in extraintestinal tumor biology and suggesting new intervention points.

15056 records 1/1004 page Next 12345 下5页 Last page